Publications by authors named "Yi Ba"

Claim this Profile
A
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study.
Ming Bai, Ning Li, Xianli Yin, Chenghui Huang, Wei Li, Yi Ba

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRAS mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials.
Jian Li, Zhenghang Wang, Jing Huang, Yi Ba, Baoshan Cao, Chunmei Bai

Lancet Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of sensory integration-based intervention in autistic children, focusing on Chinese children: a systematic review and meta-analysis.
Bingchen Lyu, Yi Ba, De Ma, Niu Liu, Limin Fu

Front Psychiatry· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Accuracy of Different Machine Learning Models in Predicting Early Neurological Deterioration after Intravenous rt‑PA Thrombolysis in Patients with Acute Ischaemic Stroke.
Yi Ba, Xiaolin Xu, Hong'an Gao, Chengguang Song

J Coll Physicians Surg Pak· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report.
Xiao-Ting Ma, Guang-Yu Yao, Jian-Li Li, Xi-Cheng Wang, Yi Ba

World J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough therapy designations in China and the United States.
Xiangyun Mao, Yi Li, Aaron S Kesselheim, Yi Ba, Guanqiao Li

Nat Rev Drug Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study.
Yuxiang Ma, Shaoyan Lin, Qun Chen, Jinhui Xue, Yunpeng Yang, Yi Ba

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety Study.
Susan M Sinclair, Yi Ba, Kayode Badejo

J Blood Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.
Zhen Guo, Anahita Ataran, Pan Ma, Wenjing Yu, Hamidreza Hajirezaei, Babak Razani, Craig T Basson

Circulation· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Pepsinogen as a Biomarker of Gastrointestinal Stromal Tumors (GIST) in Stomach.
Zhiying Gao, Laizhi Luo, Yueting Han, Yan Sun, Yonghong Huang, Jing Bai, Yi Ba

Cancer Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New species of (Nematoda: Pharyngodonidae) parasite of (Lacertilia: Agamidae) from Turpan-Hami Basin, China.
Tao Wang, Xiaofei Yan, Ziqi Jiang, Jiayi Xu, Yiyang Zhao, Yi Ba

Int J Parasitol Parasites Wildl· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.
Ming Bai, Yao Lu, Lin Shen, Xianli Yin, Shegan Gao, Yi Ba

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal choice of different neoadjuvant chemoradiotherapies for locally advanced rectal cancer: systematic review and network meta-analysis.
Lian Liu, Guangyu Yao, Junhao Yang, Yaxuan Miao, Yi Ba

Cancer Metastasis Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal miR-224-3p promotes lymphangiogenesis and lymph node metastasis by targeting GSK3B in gastric cancer.
Zhengyang Zhou, Lei Qiao, Tongtong Wang, Wen Pan, Jingjing Duan, Y I Ba

Oncol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial.
Yuankai Shi, Yi Ba, Junye Wang, Jianping Xiong, Kangsheng Gu, Yuxian Bai

Signal Transduct Target Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies.
Beryl B Cummings, Mark P Joing, Page R Bouchard, Mark N Milton, Peter F Moesta, Craig T Basson

Lancet· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Lin Shen, Yanqiao Zhang, Ziyu Li, Xiaotian Zhang, Xiangyu Gao, Yi Ba, Bangwei Cao, Yuansong Bai, Baiyong Li

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Lin Shen, Yanqiao Zhang, Ziyu Li, Xiaotian Zhang, Xiangyu Gao, Yi Ba, Bangwei Cao, Yuansong Bai, Baiyong Li

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts.
Xiaoqiang Wang, Jiaxing Jin, Han Yan, Jinhua Liu, Shan Huang, Hui Bai, Yi Ba

Sci Transl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glecirasib in KRAS-mutated nonsmall-cell lung cancer: a phase 2b trial.
Yuankai Shi, Jian Fang, Ligang Xing, Yu Yao, Jian Zhang, Yi Ba, Chunmei Bai

Nat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer.
Rui Liu, Zhi Ji, Xia Wang, Jiaqi Xin, Lila Zhu, Ming Bai, Yi Ba

Invest New Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial.
Gang Chen, Dong-Chen Sun, Yi Ba, Ya-Xiong Zhang, Ting Zhou

J Hematol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer.
Linna Gao, Tian Yao, Shaohua Ge, Jiuwei Cui, Wei Li, Yi Ba

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.
Rui Liu, Zhi Ji, Xia Wang, Lila Zhu, Jiaqi Xin, Ming Bai, Yi Ba

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chain-mediated effect of physical activity between Chinese language-based L2 motivational self-system and intended effort.
Zixia Bu, Yu Liu, Yi Ba, Shan Jiang, Huijuan Liu

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis